Aug 09, 2021 / 12:30PM GMT
Operator
Good morning, and welcome to the Biohaven Pharmaceutical's Q2 2021 Earnings Call and Webcast. (Operator Instructions) Please be advised that today's conference call may be recorded. I would now hand the conference over to Caroline [Durst] from Biohaven. Thank you. Please go ahead.
Unidentified Company Representative -
Thank you, and welcome to the Biohaven Second Quarter 2021 Earnings Call. Speaking on today's call are Dr. Vlad Coric, our Chief Executive Officer; Jim Engelhart, Chief Financial Officer; BJ Jones, Chief Commercial Officer; and Dr. Elyse Stock, Chief Medical Officer.
Earlier this morning, we issued a press release announcing the second quarter 2021 highlights. A copy of this press release can be found on our website at biohavenpharma.com, and we will file our Form 10-Q later today.
Before we begin, let me remind everyone that today's discussion contains forward-looking statements based on the environment as we currently see it and includes risks and uncertainties. A list and description of risks and uncertainties associated with an
Q2 2021 Biohaven Pharmaceutical Holding Company Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot